SCHEMBL30457430

SCHEMBL30457430

CC(C)(CNC(=O)c1ncc(-c2cccc(COc3cccc(Cl)c3)c2)cc1O)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 16/20 0.59
VEGFA P15692 4/20 0.59
FLT1 P17948 4/20 0.59
EGLN3 Q9H6Z9 4/20 0.59
TET3 O43151 1/20 0.56
BBOX1 O75936 1/20 0.56
ASPH Q12797 1/20 0.56
TET2 Q6N021 1/20 0.56
KDM8 Q8N371 1/20 0.56
OGFOD1 Q8N543 1/20 0.56
TET1 Q8NFU7 1/20 0.56
HIF1AN Q9NWT6 1/20 0.56
EGLN2 Q96KS0 4/20 0.50
NPC1 O15118 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
RAB9A P51151 1/20 0.47
PKM P14618 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25232892 1.00 EGLN1 (0.59) EGLN1VEGFAFLT1EGLN3TET3
SCHEMBL25274490 0.90 EGLN1 (0.55) EGLN1VEGFAFLT1EGLN3TET3
SCHEMBL30457510 0.90 EGLN1 (0.55) EGLN1VEGFAFLT1EGLN3TET3
SCHEMBL30457517 0.89 EGLN1 (0.71) EGLN1VEGFAFLT1EGLN3TET3
SCHEMBL25281137 0.89 EGLN1 (0.71) EGLN1VEGFAFLT1EGLN3TET3
SCHEMBL25237478 0.86 EGLN1 (0.51) EGLN1VEGFAFLT1EGLN3TET3
SCHEMBL25279944 0.85 EGLN1 (0.50) EGLN1VEGFAFLT1EGLN3TET3
SCHEMBL26183234 0.84 EGLN1 (0.47) EGLN1VEGFAFLT1EGLN3TET3
SCHEMBL30457918 0.84 EGLN1 (0.58) EGLN1VEGFAFLT1EGLN3TET3
SCHEMBL25234857 0.84 EGLN1 (0.58) EGLN1VEGFAFLT1EGLN3TET3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4447963-A1 SELECTIVE PHD1 INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Akebia Therapeutics Inc. (US) 2024-10-23 EP disclosed
CN-118715015-A Selective PHD1 inhibitor compounds, compositions and methods of use 阿克比治疗有限公司 2024-09-27 CN disclosed
WO-2023111990-A1 SELECTIVE PHD1 INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USE AKEBIA THERAPEUTICS, INC. (US) 2023-06-22 WO disclosed